Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00052637 · ClinicalTrials.gov registry record · Phase 3
Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer
A Phase 3 study, sponsored by Photocure.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00052637: Completed Phase 3 study, sponsored by Photocure.
NCT00052637 is a Phase 3 study that has completed, run by Photocure. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00052637, a Phase 3 study, has completed, sponsored by Photocure.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
RATIONALE: Diagnostic procedures such as cystoscopy may improve the ability to detect cancer and to determine the extent of disease. PURPOSE: Diagnostic trial to compare the effectiveness of cystoscopy using hexyl 5-aminolevulinate and two light sources in detecting carcinoma in situ in patients who have bladder cancer.
Interventions
- PROCEDURE biopsy
- DRUG hexaminolevulinate
- PROCEDURE cystoscopy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-09 |
| Phase | Phase 3 |
What the finished NCT00052637 record still lists
NCT00052637 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which biopsy is the first listed.
NCT00052637 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00052637 about?
NCT00052637 is a clinical study titled "Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer". RATIONALE: Diagnostic procedures such as cystoscopy may improve the ability to detect cancer and to determine the extent of disease. PURPOSE: Diagnostic trial to compare the effectiveness of cystoscopy using hexyl 5-aminolevulinate and two light sources in detecting carcinoma in situ in patients wh...
What is the current status of trial NCT00052637?
This trial is currently completed. It is a Phase 3 study. The study started on 2001-09.
What interventions are being tested in trial NCT00052637?
The interventions under investigation include: biopsy (PROCEDURE), hexaminolevulinate (DRUG), cystoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT00052637?
This trial is sponsored by Photocure, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia